| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 616 | 735 | 722 | 827 | 766 | 918 | 869 | 863 | 1,073 | 1,191 | 1,201 | 1,241 | 1,225 | 1,382 | 1,383 | 1,416 | 1,571 | 1,803 | 1,664 | 1,616 | 1,962 | 2,166 | 1,955 | 1,801 | 2,144 | 2,344 | 1,977 | 1,862 | 1,989 |
| Expenses | 487 | 588 | 558 | 631 | 602 | 715 | 663 | 669 | 831 | 878 | 887 | 970 | 945 | 1,063 | 1,060 | 1,090 | 1,198 | 1,338 | 1,198 | 1,223 | 1,443 | 1,566 | 1,344 | 1,299 | 1,486 | 1,593 | 1,389 | 1,332 | 1,381 |
| EBITDA | 129 | 147 | 164 | 196 | 165 | 204 | 206 | 194 | 242 | 314 | 314 | 272 | 280 | 319 | 323 | 326 | 374 | 465 | 466 | 394 | 519 | 600 | 611 | 502 | 658 | 751 | 588 | 530 | 608 |
| Operating Profit % | 20 % | 19 % | 21 % | 22 % | 20 % | 21 % | 22 % | 22 % | 22 % | 24 % | 24 % | 19 % | 21 % | 22 % | 22 % | 22 % | 22 % | 24 % | 26 % | 22 % | 24 % | 26 % | 29 % | 25 % | 28 % | 28 % | 27 % | 25 % | 27 % |
| Depreciation | 22 | 23 | 24 | 25 | 30 | 32 | 32 | 44 | 43 | 43 | 44 | 45 | 49 | 49 | 50 | 54 | 56 | 56 | 57 | 58 | 70 | 80 | 78 | 80 | 83 | 80 | 99 | 90 | 97 |
| Interest | 2 | 1 | 1 | 1 | 2 | 3 | 4 | 8 | 10 | 8 | 7 | 4 | 3 | 3 | 3 | 3 | 4 | 11 | 9 | 3 | 4 | 8 | 7 | 11 | 8 | 9 | 8 | 8 | 4 |
| Profit Before Tax | 105 | 123 | 140 | 170 | 133 | 169 | 170 | 142 | 190 | 263 | 264 | 222 | 228 | 267 | 269 | 269 | 314 | 398 | 400 | 333 | 445 | 512 | 526 | 411 | 566 | 663 | 481 | 432 | 507 |
| Tax | 23 | 28 | 32 | 44 | 31 | 46 | 49 | 31 | 44 | 45 | 68 | 43 | 41 | 37 | 47 | 65 | 52 | 63 | 48 | 52 | 63 | 32 | 77 | 42 | 118 | 155 | 108 | 102 | 107 |
| Net Profit | 82 | 95 | 108 | 126 | 102 | 123 | 121 | 111 | 146 | 218 | 195 | 180 | 187 | 230 | 223 | 204 | 262 | 335 | 352 | 281 | 383 | 481 | 449 | 370 | 449 | 508 | 373 | 331 | 400 |
| EPS in ₹ | 5.97 | 6.87 | 7.78 | 9.13 | 7.35 | 8.95 | 8.76 | 8.03 | 10.52 | 14.61 | 12.83 | 11.96 | 12.34 | 15.15 | 14.67 | 13.49 | 17.30 | 22.07 | 23.20 | 18.49 | 25.24 | 31.67 | 29.59 | 24.36 | 29.59 | 33.51 | 24.55 | 21.79 | 26.37 |
PI Industries
PI Industries
3,573.10
+22.80
(0.64%)
Key Fundamentals
Market Cap
53,864.50 Cr
EPS
109.44
PE Ratio
33.63
Dividend Yield
0.45 %
Industry
Chemicals 52 Week High
4,715.00
52 Week Low
2,951.10
PB Ratio
5.34
Debt to Equity
0.02
Sector
Pesticides & Agrochemicals Analyst Rating and Forecast
- By Refinitiv from22 analysts
Actual
Company News
View All News
Kumiai Chemicals has increased its financial outlook related to PI Industries. The announcement indicates an upward revision in financial projections.
PI Industries Ltd. witnessed a block trade on the National Stock Exchange involving approximately 200,277 shares at Rs. 3,580 per share, totaling Rs. 71.70 crores. The transaction represents a significant institutional or bulk trading activity in the company's shares.
PI Industries Limited held its 78th Annual General Meeting on August 14, 2025, through video conferencing. All 10 resolutions presented to shareholders were passed with the required majority. Key approvals included adoption of financial statements for the year ended March 31, 2025, confirmation of interim dividend of Rs. 6.00 per share and declaration of final dividend of Rs. 10.00 per share. Shareholders also approved the re-appointment of Mayank Singhal as Vice Chairperson & Managing Director and Rajnish Sarna as Joint Managing Director. Board appointments included Lisa J. Brown's re-appointment as Independent Director, Vegulaparanan Kasi Viswanathan's appointment as Independent Director, and Dr. Tanjore Soundararajan Balganesh's appointment as Non-Executive Non-Independent Director. Additional resolutions covered auditor appointments and remuneration ratification. The voting results showed strong shareholder support across all categories including promoter groups, institutional investors, and public shareholders.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
674.15 | #1 57,379.00 | 48.55 | #1 47,123.00 | 8.13 | 820 | 66.60 | 46.34 | |
3,573.10 | #2 53,864.50 | #6 33.63 | #2 8,322.00 | #9 5.70 | #1 1,660 | #8 -10.87 | 44.75 | |
526.40 | 25,840.80 | 47.09 | 3,268.60 | 11.19 | 506 | 40.57 | 40.80 | |
5,023.40 | 22,979.80 | 38.11 | 5,593.10 | 7.89 | 568 | 9.64 | 45.21 | |
804.10 | 7,431.00 | 17.25 | 4,379.40 | #1 35.89 | 304 | #1 423.08 | 35.11 | |
1,400.20 | 6,323.60 | 21.49 | 2,071.30 | 15.49 | 297 | 27.97 | 23.72 | |
282.35 | 5,529.70 | 31.33 | 2,631.40 | 6.54 | 164 | -274.07 | 25.92 | |
198.29 | 3,998.30 | #1 -68.82 | 1,242.60 | -30.48 | -92 | 162.50 | 37.34 | |
9,820.50 | 3,941.50 | 29.72 | 1,199.00 | 12.53 | 141 | -7.89 | 47.62 | |
244.40 | 3,134.80 | 259.41 | 449.80 | 9.63 | 14 | -29.82 | 39.00 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
5.70 %
Net Income Growth
-1.27 %
Cash Flow Change
-30.60 %
ROE
-15.11 %
ROCE
-3.01 %
EBITDA Margin (Avg.)
7.40 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,633 | 1,949 | 2,301 | 2,626 | 3,155 | 4,225 | 7,002 | 7,791 | 8,480 | 10,764 | 12,277 |
| Fixed Assets | 533 | 874 | 945 | 998 | 1,186 | 1,858 | 2,138 | 2,453 | 2,606 | 3,528 | 4,209 |
| Current Assets | 922 | 956 | 1,218 | 1,462 | 1,691 | 2,009 | 4,493 | 4,964 | 5,662 | 6,679 | 6,952 |
| Capital Work in Progress | 133 | 71 | 77 | 90 | 183 | 271 | 288 | 115 | 132 | 278 | 550 |
| Investments | 0 | 0 | 83 | 161 | 129 | 150 | 872 | 900 | 1,016 | 1,336 | 1,531 |
| Other Assets | 967 | 1,003 | 1,196 | 1,378 | 1,657 | 1,946 | 3,704 | 4,325 | 4,726 | 5,621 | 5,986 |
| Total Liabilities | 1,633 | 1,949 | 2,301 | 2,626 | 3,155 | 4,225 | 7,002 | 7,791 | 8,480 | 10,764 | 12,277 |
| Current Liabilities | 659 | 591 | 551 | 614 | 812 | 1,101 | 1,257 | 1,348 | 1,182 | 1,711 | 1,728 |
| Non Current Liabilities | 77 | 186 | 123 | 88 | 58 | 505 | 403 | 323 | 99 | 322 | 392 |
| Total Equity | 897 | 1,171 | 1,627 | 1,925 | 2,285 | 2,619 | 5,342 | 6,120 | 7,199 | 8,731 | 10,157 |
| Reserve & Surplus | 883 | 1,157 | 1,613 | 1,911 | 2,272 | 2,605 | 5,327 | 6,105 | 7,183 | 8,716 | 10,142 |
| Share Capital | 14 | 14 | 14 | 14 | 14 | 14 | 15 | 15 | 15 | 15 | 15 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -15 | 16 | 50 | 33 | -56 | 63 | -15 | 241 | 522 | 14 | -294 |
| Investing Activities | -146 | -303 | -235 | -181 | -322 | -985 | -2,430 | -110 | -496 | -1,801 | -1,421 |
| Operating Activities | 184 | 367 | 339 | 319 | 391 | 698 | 725 | 529 | 1,501 | 2,036 | 1,413 |
| Financing Activities | -53 | -48 | -53 | -106 | -125 | 350 | 1,690 | -177 | -483 | -222 | -287 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 46.74 % | 46.74 % | 46.74 % | 46.74 % | 46.74 % | 46.74 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % | 46.09 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 20.01 % | 0.00 % | 20.26 % | 18.76 % | 19.02 % | 18.46 % | 18.05 % | 16.97 % |
| DIIs | 17.77 % | 17.37 % | 16.70 % | 17.31 % | 18.50 % | 18.83 % | 26.16 % | 24.39 % | 24.21 % | 23.95 % | 23.28 % | 21.92 % | 24.34 % | 26.00 % | 26.36 % | 27.21 % | 27.57 % | 29.35 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 8.67 % | 7.99 % | 8.12 % | 8.12 % | 8.17 % | 8.12 % | 7.67 % | 8.18 % | 8.30 % | 8.37 % | 8.10 % | 7.90 % | 7.08 % | 6.95 % | 6.38 % | 6.11 % | 6.26 % | 5.68 % |
| Others | 26.82 % | 27.89 % | 28.43 % | 27.83 % | 26.58 % | 26.31 % | 20.08 % | 21.34 % | 21.40 % | 21.59 % | 2.53 % | 24.10 % | 2.22 % | 2.21 % | 2.16 % | 2.14 % | 2.02 % | 1.91 % |
| No of Share Holders | 0 | 0 | 99,487 | 1,01,416 | 1,22,989 | 1,40,279 | 1,51,138 | 1,48,043 | 1,40,720 | 1,41,092 | 1,58,268 | 1,84,515 | 1,57,991 | 1,56,790 | 1,50,190 | 1,57,993 | 1,67,265 | 1,50,401 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 4 | 4 | 4 | 4 | 5 | 6 | 10 | 15 | 16 |
| Dividend Yield (%) | 0.00 | 0.45 | 0.39 | 0.34 | 0.18 | 0.18 | 0.2 | 0.26 | 0.44 | 0.45 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 12 Feb 2021 |  Dividend | ₹ 3.00 /share | 11 Feb 2021 | 1,999.25 | 2,228.20 |
| 08 Sept 2021 | Dividend | ₹ 2.00 /share | 06 Sept 2021 | 2,741.50 | 3,365.35 |
| 15 Feb 2022 | Dividend | ₹ 3.00 /share | 14 Feb 2022 | 2,518.70 | 2,539.55 |
| 27 Aug 2022 | Dividend | ₹ 3.00 /share | 25 Aug 2022 | 2,400.55 | 3,375.25 |
| 24 Feb 2023 | Dividend | ₹ 4.50 /share | 24 Feb 2023 | 3,117.85 | 3,160.60 |
| 11 Aug 2023 | Dividend | ₹ 5.50 /share | 11 Aug 2023 | 3,256.15 | 3,876.35 |
| 21 Feb 2024 | Dividend | ₹ 6.00 /share | 21 Feb 2024 | 3,455.75 | 3,683.40 |
| 20 Aug 2024 | Dividend | ₹ 9.00 /share | 20 Aug 2024 | 3,575.30 | 4,327.90 |
| 27 Aug 2024 |  Annual General Meeting | NA | 27 Aug 2024 | 3,575.30 | 4,405.15 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 4,359.75 | 4,545.45 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 3,526.65 | 3,596.80 |
| 14 Feb 2025 | Dividend | ₹ 6.00 /share | 14 Feb 2025 | 3,596.80 | 3,226.65 |
| 19 May 2025 | Quarterly Result Announcement | NA | 19 May 2025 | 3,639.70 | 3,770.05 |
| 07 Aug 2025 | Dividend | ₹ 10.00 /share | 07 Aug 2025 | 3,770.05 | 4,085.70 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 4,137.10 | 3,853.70 |
| 14 Aug 2025 | Annual General Meeting | NA | 14 Aug 2025 | 3,770.05 | 3,772.70 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 days ago
9 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 03, 2025
Oct 03, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Oct 03, 2025
Oct 03, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 23, 2025
Sep 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 19, 2025
Sep 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 08, 2025
Sep 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 21, 2025
Aug 21, 2025Saksham Niveshak - 100 Days Campaign - Request To Shareholders To Update KYC Details And Claim Unpaid/Unclaimed DividendsAug 21, 2025
Aug 21, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 14, 2025
Aug 14, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 12, 2025
Aug 12, 2025Results For The Quarter Ended June 30 2025Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2025
Aug 05, 2025Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025Aug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 25, 2025
Jul 25, 2025Intimation Under Regulation 30 Of SEBI Listing Regulations 2015- Letter To Shareholders Under Regulation 36(1)(B)Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 23, 2025
Jul 23, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 21, 2025
Jul 21, 2025Reg. 34 (1) Annual Report.Jul 21, 2025
Jul 21, 2025Notice Of Annual General Meeting To Be Held On August 14 2025Jul 21, 2025
Jul 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 19, 2025
Jul 19, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 20, 2025
Jun 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Jun 17, 2025Clarification On Volume Movement Letter Dated June 17 2025Jun 17, 2025
Jun 17, 2025Mutual Fund Holdings
Axis Midcap Direct Plan-Growth 
ICICI Prudential Business Cycle Fund Direct - Growth 
Edelweiss Large & Mid Cap Direct Plan-Growth 
Mirae Asset Midcap Fund Direct - Growth 
Kotak Arbitrage Fund Direct-Growth 
Aditya Birla Sun Life Large Cap Direct Fund-Growth 
HSBC Flexi Cap Fund Direct-Growth 
UTI BSE Low Volatility Index Fund Direct - Growth 
Tata India Pharma & Healthcare Fund Direct-Growth 
Sundaram Large Cap Fund Direct - Growth 
DSP Midcap Direct Plan-Growth 
SBI Arbitrage Opportunities Fund Direct-Growth 
Mahindra Manulife Large & Mid Cap Fund Direct - Growth 
Baroda BNP Paribas Innovation Fund Direct - Growth 
Canara Robeco Large Cap Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 44.75
ATR(14)
Volatile 79.50
STOCH(9,6)
Neutral 38.75
STOCH RSI(14)
Overbought 86.55
MACD(12,26)
Bullish 10.07
ADX(14)
Weak Trend 20.00
UO(9)
Bearish 52.24
ROC(12)
Uptrend And Accelerating 1.70
WillR(14)
Neutral -53.25
About PI Industries
PI Industries Limited is an agri-sciences company operating in both domestic and export markets. It has three manufacturing facilities in Gujarat and a Research & Development center in Udaipur. The company focuses on two main segments: Agro chemicals and Pharma. In the Agro chemicals segment, PI Industries engages in custom synthesis and manufacturing (CSM) for exports and domestic agri brands. The Pharma segment involves contract research, development, and manufacturing of active materials and intermediates for the pharmaceutical industry. PI Industries offers various services, including R&D, CSM, and distribution. Its product portfolio includes insecticides, fungicides, herbicides, and specialty products. The company has expanded through acquisitions, joint ventures, and investments in new facilities. PI Industries has also diversified into electronic chemicals and established international presence with offices in Germany and subsidiaries in the Netherlands and the United States.
Website
Chairperson NameNarayan K Seshadri
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
